Your browser doesn't support javascript.
loading
Antitumour Activity and Safety of Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Abiraterone Acetate Plus Prednisone for ≥24 weeks in Europe.
de Bono, Johann S; Chowdhury, Simon; Feyerabend, Susan; Elliott, Tony; Grande, Enrique; Melhem-Bertrandt, Amal; Baron, Benoit; Hirmand, Mohammad; Werbrouck, Patrick; Fizazi, Karim.
Affiliation
  • de Bono JS; The Institute of Cancer Research, London, UK. Electronic address: johann.de-bono@icr.ac.uk.
  • Chowdhury S; Guy's Hospital, London, UK; King's Hospital, London, UK; St Thomas' Hospital, London, UK.
  • Feyerabend S; Studienpraxis Urologie, Nürtingen, Germany.
  • Elliott T; The Christie Hospital, Manchester, UK.
  • Grande E; Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Melhem-Bertrandt A; Astellas Pharma, Inc, Northbrook, IL, USA.
  • Baron B; Astellas Pharma, Inc, Leiden, the Netherlands.
  • Hirmand M; Medivation, Inc, which was acquired by Pfizer, Inc in September 2016, San Francisco, CA, USA.
  • Werbrouck P; AZ Groeninge, Kortrijk, Belgium.
  • Fizazi K; Institut Gustave Roussy, Paris-Sud University, Villejuif, France.
Eur Urol ; 74(1): 37-45, 2018 07.
Article in En | MEDLINE | ID: mdl-28844372

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Prednisone / Antineoplastic Combined Chemotherapy Protocols / Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate / Androgen Antagonists Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur Urol Year: 2018 Document type: Article Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Prednisone / Antineoplastic Combined Chemotherapy Protocols / Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate / Androgen Antagonists Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur Urol Year: 2018 Document type: Article Country of publication: Switzerland